These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33155940)

  • 1. [Diagnostic and Prognostic Markers of Chronic Heart Failure in Patients with Occupational Chronic Obstructive Pulmonary Disease].
    Shpagina LA; Kamneva NV; Kudelya LM; Kotova OS; Shpagin IS; Kuznetsova GV; Anikina EV; Gerasimenko DA; Saraskina LE; Surovenko TN; Ponomareva AV
    Kardiologiia; 2020 Aug; 60(7):44-52. PubMed ID: 33155940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COPD in chronic heart failure: less common than previously thought?
    Minasian AG; van den Elshout FJ; Dekhuijzen PN; Vos PJ; Willems FF; van den Bergh PJ; Heijdra YF
    Heart Lung; 2013; 42(5):365-71. PubMed ID: 23998385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis.
    Guazzi M; Bandera F; Pelissero G; Castelvecchio S; Menicanti L; Ghio S; Temporelli PL; Arena R
    Am J Physiol Heart Circ Physiol; 2013 Nov; 305(9):H1373-81. PubMed ID: 23997100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of N-terminal pro-type-B natriuretic peptide and Doppler left ventricular diastolic variables in patients with chronic systolic heart failure stabilized by therapy.
    Dini FL; Conti U; Fontanive P; Andreini D; Panicucci E; De Tommasi SM
    Am J Cardiol; 2008 Aug; 102(4):463-8. PubMed ID: 18678307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of chronic obstructive pulmonary disease on adverse prognosis in hospitalized heart failure patients with preserved ejection fraction - A report from the JASPER registry.
    Sato Y; Yoshihisa A; Oikawa M; Nagai T; Yoshikawa T; Saito Y; Yamamoto K; Takeishi Y; Anzai T
    J Cardiol; 2019 Jun; 73(6):459-465. PubMed ID: 30718015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for asymptomatic heart failure with preserved ejection fraction in mongolian population at high risk.
    Unurjargal T; Khorloo C; Ulziisaikhan G; Sodovsuren N; Khasag A
    Kardiologiia; 2020 Mar; 60(4):86-90. PubMed ID: 32394862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of chronic obstructive pulmonary diseases on left ventricular diastolic function in hospitalized elderly patients.
    Huang YS; Feng YC; Zhang J; Bai L; Huang W; Li M; Sun Y
    Clin Interv Aging; 2015; 10():81-7. PubMed ID: 25565790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of diagnostic criteria of heart failure in patients with atrial fibrillation and chronic obstructive pulmonary disease].
    Dzyurich TA; Chesnikova AI; Terentyev VP; Kolomatskaya OE; Safronenko VA
    Kardiologiia; 2019 Sep; 59(10S):4-12. PubMed ID: 31876457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of heart failure patients with reduced and preserved ejection fraction and coexistent chronic obstructive pulmonary disease.
    Kwon BJ; Kim DB; Jang SW; Yoo KD; Moon KW; Shim BJ; Ahn SH; Cho EJ; Rho TH; Kim JH
    Eur J Heart Fail; 2010 Dec; 12(12):1339-44. PubMed ID: 20861127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart failure with preserved left ventricular ejection fraction in patients with obstructive sleep apnea syndrome: prognostic value of biomarkers.
    Grakova EV; Yakovlev AV; Shilov SN; Berezikova EN; Kopeva KV; Yakovleva NF; Ogurkova ON; Teplyakov AT
    Kardiologiia; 2021 Nov; 61(11):77-88. PubMed ID: 34882081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure.
    Khanam SS; Choi E; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ; Yoo BS
    PLoS One; 2018; 13(11):e0206380. PubMed ID: 30485284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials.
    Brunner-La Rocca HP; Eurlings L; Richards AM; Januzzi JL; Pfisterer ME; Dahlström U; Pinto YM; Karlström P; Erntell H; Berger R; Persson H; O'Connor CM; Moertl D; Gaggin HK; Frampton CM; Nicholls MG; Troughton RW
    Eur J Heart Fail; 2015 Dec; 17(12):1252-61. PubMed ID: 26419999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic obstructive pulmonary disease in patients admitted with heart failure.
    Iversen KK; Kjaergaard J; Akkan D; Kober L; Torp-Pedersen C; Hassager C; Vestbo J; Kjoller E;
    J Intern Med; 2008 Oct; 264(4):361-9. PubMed ID: 18537871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.
    Okuyama R; Ishii J; Takahashi H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Naruse H; Sarai M; Hasegawa M; Watanabe E; Suzuki A; Hayashi M; Izawa H; Yuzawa Y; Ozaki Y
    Heart Vessels; 2017 Jul; 32(7):880-892. PubMed ID: 28154958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Natriuretic peptides as markers of development and prognosis of pulmonary hypertension severity in patients with chronic obstructive disease.].
    Avdeev SN; Gaynitdinova VV; Tsareva NA; Merzhoeva ZM
    Klin Lab Diagn; 2018; 63(6):333-337. PubMed ID: 30702222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart failure in patients with COPD exacerbations: Looking below the tip of the iceberg.
    Hesse K; Bourke S; Steer J
    Respir Med; 2022 May; 196():106800. PubMed ID: 35306385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms Underlying the Association of Chronic Obstructive Pulmonary Disease With Heart Failure.
    Lagan J; Schelbert EB; Naish JH; Vestbo J; Fortune C; Bradley J; Belcher J; Hearne E; Ogunyemi F; Timoney R; Prescott D; Bain HDC; Bangi T; Zaman M; Wong C; Ashworth A; Thorpe H; Egdell R; McIntosh J; Irwin BR; Clark D; Devereux G; Quint JK; Barraclough R; Schmitt M; Miller CA
    JACC Cardiovasc Imaging; 2021 Oct; 14(10):1963-1973. PubMed ID: 34023272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study.
    Pervez MO; Winther JA; Brynildsen J; Strand H; Christensen G; Høiseth AD; Myhre PL; Røysland R; Lyngbakken MN; Omland T; Røsjø H
    Biomarkers; 2018 Nov; 23(7):654-663. PubMed ID: 29733687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.